로딩 중…
지수 로딩 중…
ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CN
CN$16.80-3.59%
2026-08-03
Financials
Valuation Metrics
ASCENTAGE PHARMA GROUP INTERNATIONAL's Market Cap is $1.57B. Ranked #2218 of 3,112 in US market (top 71%), #878 of 1,445 on NASDAQ (top 61%), #160 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 59%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.57B | US#2,218/3,112 Sec#160/269 |
| Revenue | $78M | US#2,825/3,112 Sec#139/269 |
| Net Income | $-168M | US—/3,112 Sec—/269 |
| Total Assets | $567M | US#2,697/3,112 Sec#140/269 |
| Net Assets | $189M | US#2,751/3,112 Sec#202/269 |
| Value | ||
| P/B | 8.28x | US#2,514/3,112 Sec#194/269 |
| P/S | 20.18x | US#2,816/3,112 Sec#146/269 |
| FCF Yield | -10.66% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -88.81% | US#2,838/3,112 Sec#216/269 |
| ROA | -29.68% | US#2,870/3,112 Sec#162/269 |
| Op. Margin | -211.14% | US#2,863/3,112 Sec#140/269 |
| Revenue Growth | -43.05% | US#2,863/3,112 Sec#162/269 |
| Financial Health | ||
| Debt Ratio | 198.52% | US#1,779/3,112 Sec#200/269 |
| Total Debt | $283M | US#2,061/3,112 Sec#79/269 |
| FCF | $-167M | US#2,699/3,112 Sec#198/269 |
| Cash | $353M | US#1,311/3,112 Sec#72/269 |
| Current Ratio | 1.79x | US#1,389/3,112 Sec#236/269 |
| Performance | ||
| 1Y Return | -54.83% | US#3,011/3,112 Sec#251/269 |
| 1M Return | -9.16% | US#2,549/3,112 Sec#158/269 |
| From 52W High | -65.31% | US#2,980/3,112 Sec#246/269 |
| 1Y MDD | -64.99% | US#2,834/3,112 Sec#234/269 |
| Trading | ||
| Volume | 14,148 shares | US#3,102/3,112 Sec#268/269 |
| Trading Value | $241081.00 | US#3,100/3,112 Sec#268/269 |